Synthesis and biological evaluation of PET tracers designed for imaging of calcium acti-vated potassium channel 3.1 (KCa3.1) channels in vivo.

Brömmel, K., Konken, C.P. (shared first authorship), Börgel, F., Obeng-Darko, H., Schel-haas, S., Bulk, E., Budde, T., Schwab, A., Schäfers, M., Wünsch, B. (2021)
In: RSC Advances, 11
Type of Publication: Research article (journal)

Combined PET imaging of the inflammatory tumor microenvironment identifies margins of unique radiotracer uptake.

Zinnhardt B, Pigeon H, Thézé B, Viel T, Wachsmuth L, Fricke IB, Schelhaas S, Honold L, Schwegmann K, Wagner S, Faust A, Faber C, Kuhlmann MT, Hermann S, Schäfers M, Winkeler A, Jacobs AH. (2017)
In: Cancer Research, 77(8)
Type of Publication: Research article (journal)

The relationship between endogenous thymidine concentrations and [18F]FLT uptake in a range of preclinical tumour models.

Heinzmann K, Honess D, Lewis D, Smith D, Cawthorne C, Keen H, Heskamp S, Schelhaas S, Witney T, Soloviev D, Williams K, Jacobs A, Aboagye E, Griffiths J, Brindle K. (2016)
In: EJNMMI Research, 6(1)
Type of Publication: Research article (journal)

Gemcitabine mechanism of action confounds early assessment of treatment response by 3′-Deoxy-3′-[18F]fluorothymidine in preclinical models of lung cancer.

Schelhaas S, Held A, Wachsmuth L, Hermann S, Honess D, Heinzmann K, Smith D, Griffiths J, Faber C, Jacobs A. (2016)
In: Cancer Research, 76(24)
Type of Publication: Research article (journal)

Antibody-mediated delivery of anti-KRAS-siRNA in vivo overcomes therapy resistance in colon cancer

Bäumer S., Bäumer N., Appel N., Terheyden L., Fremerey J., Schelhaas S., Wardelmann E., Buchholz F., Berdel W., Müller-Tidow C. (2015)
In: Clinical Cancer Research, 21(6)
Type of Publication: Research article (journal)

Publications

Contact

Top-Links

Synthesis and biological evaluation of PET tracers designed for imaging of calcium acti-vated potassium channel 3.1 (KCa3.1) channels in vivo. Brömmel, K., Konken, C.P. (shared first authorship), Börgel, F., Obeng-Darko, H., Schel-haas, S., Bulk, E., Budde, T., Schwab, A., Schäfers, M., Wünsch, B. (2021) In: RSC Advances, 11 Type of Publication: Research article (journal)
Prophylactic Antiviral Activity of Sulfated Glycomimetic Oligomers and Polymers Soria-Martinez, Laura; Bauer, Sebastian; Giesler, Markus; Schelhaas, Sonja; Materlik, Jennifer; Janus, Kevin; Pierzyna, Patrick; Becker, Miriam; Snyder, Nicole L.; Hartmann, Laura; Schelhaas, Mario (2020) In: Journal of the American Chemical Society, 142(11) Type of Publication: Research article (journal)
Combined PET imaging of the inflammatory tumor microenvironment identifies margins of unique radiotracer uptake. Zinnhardt B, Pigeon H, Thézé B, Viel T, Wachsmuth L, Fricke IB, Schelhaas S, Honold L, Schwegmann K, Wagner S, Faust A, Faber C, Kuhlmann MT, Hermann S, Schäfers M, Winkeler A, Jacobs AH. (2017) In: Cancer Research, 77(8) Type of Publication: Research article (journal)
In vivo bioluminescence imaging of neurogenesis - the role of the blood brain barrier in an experimental model of Parkinson's disease. Fricke IB, Schelhaas S, Zinnhardt B, Viel T, Hermann S, Couillard-Després S, Jacobs AH. (2017) In: Eur J Neurosci., ejn.13540 Type of Publication: Research article (journal)
The relationship between endogenous thymidine concentrations and [18F]FLT uptake in a range of preclinical tumour models. Heinzmann K, Honess D, Lewis D, Smith D, Cawthorne C, Keen H, Heskamp S, Schelhaas S, Witney T, Soloviev D, Williams K, Jacobs A, Aboagye E, Griffiths J, Brindle K. (2016) In: EJNMMI Research, 6(1) Type of Publication: Research article (journal)
Preclinical evidence that 3′-deoxy-3′-[18F]fluorothymidine PET can visualize recovery of hematopoiesis after gemcitabine chemotherapy. Schelhaas S, Held A, Bäumer N, Viel T, Hermann S, Müller-Tidow C, Jacobs A. (2016) In: Cancer Research, 76(24) Type of Publication: Research article (journal)
Gemcitabine mechanism of action confounds early assessment of treatment response by 3′-Deoxy-3′-[18F]fluorothymidine in preclinical models of lung cancer. Schelhaas S, Held A, Wachsmuth L, Hermann S, Honess D, Heinzmann K, Smith D, Griffiths J, Faber C, Jacobs A. (2016) In: Cancer Research, 76(24) Type of Publication: Research article (journal)
PEGylated human serum albumin (HSA) nanoparticles: Preparation, characterization and quantification of the PEGylation extent. Fahrländer E., Schelhaas S., Jacobs A., Langer K. (2015) In: Nanotechnology, 26(14) Type of Publication: Research article (journal)
Antibody-mediated delivery of anti-KRAS-siRNA in vivo overcomes therapy resistance in colon cancer Bäumer S., Bäumer N., Appel N., Terheyden L., Fremerey J., Schelhaas S., Wardelmann E., Buchholz F., Berdel W., Müller-Tidow C. (2015) In: Clinical Cancer Research, 21(6) Type of Publication: Research article (journal)
Epigenetic dysregulation of KCa 3.1 channels induces poor prognosis in lung cancer. Bulk E, Ay A, Hammadi M, Ouadid-Ahidouch H, Schelhaas S, Hascher A, Rohde C, Thoennissen NH, Wiewrodt R, Schmidt E, Marra A, Hillejan L, Jacobs AH, Klein H, Dugas M, Berdel WE, Muller-Tidow C, Schwab A (2015) In: International Journal of Cancer, 137(6) Type of Publication: Research article (journal)